Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women
Sponsor: Oregon Health and Science University
This PHASE2 trial investigates Polycystic Ovary Syndrome (PCOS) and is currently completed. Oregon Health and Science University leads this study, which shows 13 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Feb 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Feb 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jun 2024 — Jul 2024 [monthly]
Completed PHASE2
-
Aug 2023 — Jun 2024 [monthly]
Completed PHASE2
Status: Recruiting → Completed
▶ Show 8 earlier versions
-
Jun 2022 — Aug 2023 [monthly]
Recruiting PHASE2
-
Dec 2021 — Jun 2022 [monthly]
Recruiting PHASE2
-
Jan 2021 — Dec 2021 [monthly]
Recruiting PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Oct 2019 — Dec 2020 [monthly]
Recruiting PHASE2
-
Sep 2018 — Oct 2019 [monthly]
Recruiting PHASE2
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Apr 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Oregon Health and Science University
- University of California, Los Angeles
For direct contact, visit the study record on ClinicalTrials.gov .